Skip to main content
. Author manuscript; available in PMC: 2018 Jan 22.
Published in final edited form as: Bone Marrow Transplant. 2009 Jul 27;45(3):498–504. doi: 10.1038/bmt.2009.176

Table 2.

Flow pattern of treatment for 758 previously untreated patients

graphic file with name nihms896782f5.jpg
a

Dexamethasone alone, or with IFN, melphalan or VAD. A total of 306 patients received later TD or BTD with disease resistance or relapse, including 123 patients who had not received HDT.

b

TD = thalidomide, dexamethasone. BTD = bortezomib, thalidomide, dexamethasone. All patients received TD or BTD upon relapse, including 40 patients who had not received HDT.

c

Twenty-two patients had achieved CR after 1 year (19 with earlier PR and 3 with earlier NR).